Directions For Use:
SINGESTAR
A Progestogen Treatment
Singestar injectable ®
Directions for use:
After weaning:
Familiarize yourself with the anestrous period of your pet,
or,
use 3 to 6 weeks as a subsequent basis for the manifestation of the estrus.
After the manifestation of estrus,
this procedure may fail if the condition is not treated within 1 week,
(7 days, actual),
postweaning.
It is important to confirm the stage of the estrous cycle by studying the animal,
through observation of vaginal smears.
This treatment must be supervised by a Veterinary doctor, and in its administration by the Veterinary doctor, breeder,or the owner of the animal.
Singestar ® MP should be adjusted according the individual sensitivity of each animal,
taking into account the possibility of Anaphylactic reactions and to observe any side effects.
Progestogen treatments may causes serious side effects in animals accutely susceptible to adverse effects.
Alternatives should be considered when deemed as safe, thus deciding whether or not to use a hormone treatment.
This procedure should be administered in animals with no history of uterine disorders and / or breast malignancy, problem pregnancys, or female diabetes mellitus.
It should not be applied during the period of proestrus, estrus and diestrus.
An injection at the onset of estrus controls for up to a 6-month period, although this duration may vary.
Once your your pet reaches the age of Eleven, discontinue treatment.
Singest ® MP must be stored between
4 ° and 30 ° C
(39*and 86*F)
Singest ® MP is to be administered after you or your vet confirm the animal is in the anoestrous season,
(ideally 20-30 days prior to the initiation of proestro),
(ideally 20-30 days prior to the initiation of proestro),
(proestrus).
It is important to confirm the stage of the estaoestrus period and confirming the animals level of gesdation through use of vaginal smears.
In cats this is often difficult.
Administration:
Canine and Feline
Subcutaneous injection in the area of the groin or armpit, as Medroxyprogesterone may cause local alopecia, skin discoloration or depigmentation,
at the injection site.
.